establish
etiolog
respiratori
tract
infect
rti
often
difficult
due
lack
diagnost
gold
standard
inabl
detect
caus
pathogen
larg
proport
rti
believ
caus
respiratori
virus
widespread
avail
molecular
method
multiplex
realtim
polymeras
chain
reaction
rtpcr
clinic
workflow
chang
dramat
sensit
viral
diagnost
increas
remark
compar
convent
method
howev
signific
viru
detect
remain
unclear
presenc
viru
prove
causal
mani
respiratori
virus
carri
asymptomat
children
shed
prolong
period
thu
discrimin
carriag
infect
challeng
viral
infect
report
previous
predispos
bacteri
superinfect
concern
possibl
bacteri
coinfect
remain
rule
bacteri
infect
tradit
microbiolog
techniqu
frequent
imposs
predict
valu
clinic
sign
differenti
viral
bacteri
infect
also
low
ground
clinic
manag
patient
respiratori
viru
diagnosi
controversi
surprisingli
poorli
studi
overal
extens
yet
often
unnecessari
use
antibiot
rti
common
adult
pediatr
retrospect
cohort
studi
analyz
whether
identif
viru
multiplex
rtpcr
associ
chang
antibiot
treatment
retrospect
cohort
studi
pediatr
adult
outpati
rtpcr
assay
respiratori
virus
perform
upper
lower
rti
either
kantonsspit
st
gallen
children
hospit
eastern
switzerland
hospit
tertiarycar
swiss
teach
hospit
activ
infecti
diseas
consult
servic
easili
access
webbas
local
guidelin
wwwguidelinesch
treatment
communityacquir
hospitalacquir
pneumonia
guidelin
strongli
recommend
use
strictli
reinforc
includ
use
rtpcr
option
diagnost
hospit
patient
particularli
immun
suppress
studi
period
septemb
assay
introduc
novemb
document
applic
date
antiinfect
medic
match
date
rtpcr
analysi
order
determin
whether
treatment
chang
respons
rtpcr
result
main
outcom
interest
whether
antibiot
therapi
modifi
accord
result
multiplex
rtpcr
secondari
outcom
preval
distribut
posit
result
rtpcr
complic
length
stay
lo
antibiot
therapi
depend
identifi
pathogen
identifi
patient
databas
centr
laboratori
medicin
search
medic
record
retrospect
analyz
obtain
basic
demograph
clinic
laboratori
radiolog
paramet
data
clinic
manag
chest
radiograph
cxr
comput
tomographi
ct
adult
children
review
pulmonologist
pediatrician
respect
rtpcr
result
avail
within
hour
test
applic
date
antiinfect
medic
document
medic
record
correl
day
day
rtpcr
analysi
order
defin
whether
treatment
initi
discontinu
associ
result
viral
test
identifi
pathogen
retrospect
determin
relev
infecti
diseas
specialist
integr
avail
inform
etiolog
divid
four
mutual
exclus
group
bacteri
bacteria
ii
viral
respiratori
virus
iii
mix
bacteria
respiratori
virus
iv
pathogen
includ
fungi
nonrespiratori
viru
bacteri
contamin
includ
coagulaseneg
staphylococci
propionibacterium
corynebacterium
colon
oral
respiratori
flora
children
rapid
detect
test
aler
binaxnow
influenza
b
quidel
quickvu
rsv
test
respiratori
syncyti
viru
rsv
influenza
ab
viru
avail
result
addit
consid
form
differ
group
patient
chang
antibiot
manag
ie
either
start
stop
antibiot
determin
situat
defin
chang
manag
consid
correct
viral
infect
antibiot
treatment
rtpcr
antibiot
stop
posit
rtpcr
result
becam
avail
bacteri
mix
infect
antibiot
given
rtpcr
start
neg
rtpcr
result
patient
indic
rti
antibiot
therapi
exclud
patient
febril
neutropenia
without
specif
focu
antibiot
indic
defin
antibiot
would
usual
stop
despit
viral
detect
patient
underw
repeat
test
respiratori
virus
within
week
first
posit
result
count
time
interv
longer
detect
virus
diverg
differ
episod
presum
analyz
separ
reflect
clinic
decis
make
reallif
situat
subanalys
perform
case
without
detect
bacteria
ie
patient
viral
etiolog
pathogen
evalu
clinic
bacteri
fulfil
one
follow
criteria
unilobar
multilobar
pulmonari
infiltr
ct
cxr
creactiv
protein
crp
mgl
procalcitonin
pct
antibiot
therapi
rtpcr
indetermin
biomark
crp
mgl
pct
crp
mgl
pct
avail
criteria
adapt
earlier
public
regard
diagnosi
bacteri
lower
rti
subgroup
patient
viral
etiolog
clinic
bacteri
infect
consid
clinic
viral
infect
children
year
adult
year
analyz
separ
sepsi
defin
accord
standard
criteria
time
system
inflammatori
respons
syndrom
sir
criteria
children
defin
agespecif
imag
patient
interstiti
infiltr
ground
glass
opac
absenc
unilobar
multilobar
infiltr
therapi
atyp
pathogen
macrolid
quinolon
tetracyclin
antibiot
coverag
typic
bacteri
pathogen
consid
appropri
cxr
ct
avail
ct
read
use
analys
infiltr
requir
diagnosi
pneumonia
radiographi
need
diagnos
rti
gener
multiplex
rtpcr
perform
accord
manufactur
instruct
seegen
korea
ii
detect
kit
seegen
korea
detect
follow
virus
adenoviru
influenza
viru
influenza
b
viru
parainfluenza
viru
parainfluenza
viru
parainfluenza
viru
parainfluenza
viru
rhinoviru
abc
rsv
rsv
b
bocaviru
human
metapneumoviru
coronaviru
coronaviru
coronaviru
enteroviru
specimen
arriv
midmorn
monday
friday
process
daili
result
provid
midafternoon
specimen
arriv
afterward
process
follow
workday
report
midafternoon
date
specimen
collect
test
avail
date
time
report
result
crp
white
blood
cell
count
wbc
platelet
patholog
valu
within
day
rtpcr
result
document
quantit
variabl
describ
mean
standard
deviat
median
interquartil
rang
iqr
appropri
qualit
variabl
present
absolut
count
rel
percentag
fisher
exact
test
use
compar
proport
appropri
continu
variabl
independ
ttest
mannwhitneyutest
use
pvalu
consid
statist
signific
multivari
logist
regress
use
examin
whether
differ
predictor
associ
viru
detect
variabl
pvalu
univari
logist
regress
includ
spss
version
window
softwar
openepi
wwwopenepicom
microsoft
excel
use
statist
analys
baselin
characterist
present
tabl
one
hundr
seven
patient
femal
children
mean
age
group
viral
infect
lower
remain
patient
vs
year
p
differ
signific
children
adult
analyz
separ
children
vs
year
p
adult
vs
year
p
patient
neutropenia
hematolog
malign
collagen
vascular
diseasevascul
viral
group
p
p
p
diagnosi
bronchiti
upper
rti
common
viral
group
p
p
pathogen
identifi
patient
adult
children
among
patient
one
respiratori
viru
detect
one
bacteria
mix
viralbacteri
infect
patient
children
infect
one
respiratori
virus
compar
children
viral
detect
adult
less
frequent
n
p
singl
pathogen
identifi
patient
multipl
pathogen
detect
patient
distribut
detect
pathogen
differ
children
adult
shown
tabl
fig
b
patient
cohort
receiv
antibiot
hospit
outpati
receiv
antibiot
time
rtpcr
test
patient
viral
etiolog
receiv
antibiot
time
point
children
adult
inpati
bacteri
etiolog
treat
antibiot
p
longer
viral
etiolog
pathogen
p
p
children
adult
analyz
individu
similar
nonsignific
trend
observ
tabl
effect
rtpcr
analysi
antibiot
manag
present
tabl
exclus
patient
receiv
antibiot
indic
viru
detect
tempor
associ
discontinu
antibiot
adult
children
patient
viral
etiolog
manag
frequent
judg
correct
children
adult
p
rtpcr
result
becam
avail
adult
manag
viral
etiolog
less
often
judg
correct
compar
adult
bacteri
etiolog
p
among
patient
clinic
viral
etiolog
children
frequent
manag
correctli
adult
p
eight
adult
one
child
receiv
oseltamivir
four
five
patient
proven
influenza
viru
infect
antivir
medic
prescrib
respons
posit
rtpcr
analysi
anoth
child
oseltamivir
commenc
third
success
detect
influenza
viru
within
month
stop
day
two
patient
antivir
therapi
start
continu
despit
rtpcr
analysi
neg
influenza
posit
respiratori
virus
anoth
patient
identif
bacteri
pathogen
oseltamivir
stop
neg
rtpcr
result
avail
addit
case
detect
bacteria
antivir
medic
start
day
rtpcr
analysi
stop
next
day
hospit
length
stay
lo
longer
patient
bacteri
etiolog
compar
patient
viral
etiolog
children
lo
significantli
vari
differ
group
viral
bacteri
etiolog
tabl
patient
mix
infect
frequent
admit
intens
care
unit
icu
mechan
ventil
compar
patient
viral
etiolog
p
p
respect
children
adult
analyz
separ
differ
within
adult
popul
signific
children
patient
mix
infect
mechan
ventil
p
allcaus
rtiassoci
mortal
compar
pathogen
group
patient
viral
etiolog
differ
mortal
discontinu
antibiot
compar
vs
p
lo
shorter
inpati
discontinu
antibiot
median
day
iqr
vs
iqr
p
patient
antibiot
continu
despit
viral
detect
frequent
admit
icu
vs
p
mechan
ventil
vs
p
patient
antibiot
discontinu
proport
patient
sepsi
compar
vs
p
result
similar
adult
children
analyz
separ
normal
cxr
find
significantli
frequent
patient
viral
infect
compar
bacteri
infect
vs
p
multilobar
infiltr
pleural
effus
cxr
observ
less
often
among
subject
viral
infect
tabl
multivari
logist
regress
tabl
absenc
pleural
effus
adult
associ
detect
respiratori
virus
odd
ratio
confid
interv
ci
children
lack
multilobar
infiltr
signific
predictor
respiratori
viru
detect
ci
three
main
find
retrospect
cohort
studi
impact
viral
multiplex
rtpcr
first
major
patient
viral
rti
receiv
antibiot
antibiot
discontinu
viral
detect
minor
patient
second
biomark
radiolog
present
antibiot
pretreat
taken
account
categori
clinic
bacteri
clinic
viral
infect
creat
close
reflect
clinic
decis
make
multiplex
rtpcr
show
greater
impact
consider
improv
correct
manag
clinic
viral
infect
among
children
among
adult
third
impact
rtpcr
test
seem
accentu
children
adult
children
adult
appropri
discontinu
antibiot
overal
manag
viral
infect
superior
children
compar
adult
importantli
caveat
small
number
evid
outcom
wors
viral
etiolog
discontinu
antibiot
compar
sever
previou
studi
analyz
impact
rapid
avail
rtpcr
result
antibiot
use
random
control
trial
rct
adult
lower
rti
antibiot
partial
total
discontinu
patient
rtpcr
result
avail
albeit
without
overal
reduct
antibiot
treatment
durat
control
clinic
trial
enrol
children
acut
rti
wishaupt
et
al
evalu
diagnost
yield
effect
rapid
commun
rtpcr
result
within
h
vs
week
test
fail
show
signific
influenc
durat
antibiot
treatment
contrast
brittainlong
et
al
demonstr
rct
adult
patient
random
rapid
rtpcr
result
receiv
antibiot
less
frequent
acut
rti
primari
care
set
initi
visit
vs
p
howev
followup
prescript
rate
similar
vs
p
contrari
find
retrospect
prepost
studi
children
show
introduct
expand
multiplex
rtpcr
shorter
turnaround
time
decreas
durat
antibiot
use
vs
day
p
without
reduc
proport
antibiot
prescript
previou
studi
typic
respiratori
bacteria
includ
test
panel
due
technic
limit
miss
treatabl
pathogen
concern
light
potenti
bacterialvir
coinfect
shown
clinic
suspicion
bacteri
superinfect
one
reason
physician
stop
antibiot
rtpcrposit
patient
tri
partial
overcom
creat
categori
clinic
bacteri
clinic
viral
infect
definit
aid
provid
biomark
criterion
account
possibl
viral
infect
set
bacteri
carriag
one
major
differ
advantag
current
studi
compar
previou
public
assess
impact
rtpcr
result
limit
impact
appropri
therapi
also
integr
realworld
clinic
radiolog
paramet
decis
process
advanc
molecular
diagnost
test
interpret
context
avail
clinic
diagnost
inform
order
improv
clinic
manag
result
confirm
import
role
clinic
judgement
appropri
antibiot
prescript
rtpcr
provid
addit
inform
rather
sole
respons
treatment
decis
quantif
genom
viral
load
might
improv
specif
viru
detect
higher
organ
burden
associ
higher
risk
complic
sever
diseas
adult
children
unfortun
quantit
result
avail
appli
assay
similarli
optim
time
molecular
test
relat
symptom
onset
inclus
everexpand
number
respiratori
virus
might
import
increas
sensit
howev
author
knowledg
yet
studi
whether
either
two
factor
would
improv
clinic
manag
pathogen
identifi
patient
studi
accord
detect
rate
studi
rang
mix
bacterialvir
etiolog
found
patient
previous
describ
rate
vari
studi
suggest
mix
bacterialvir
infect
result
sever
clinic
diseas
measur
score
pneumonia
sever
index
higher
rate
mechan
ventil
longer
durat
icu
care
longer
hospit
stay
higher
mortal
studi
studi
mix
bacterialvir
infect
associ
higher
rate
icu
admiss
mechan
ventil
compar
pure
viral
p
p
pure
bacteri
p
p
infect
patient
consid
howev
result
view
repres
etiolog
lower
rti
east
switzerland
hospit
present
preselect
group
patient
agreement
find
studi
contrast
other
studi
fail
identifi
specif
predictor
viral
detect
multivari
logist
regress
advanc
age
previous
describ
common
viral
infect
evid
inconclus
studi
younger
age
signific
predictor
viru
detect
univari
logist
regress
patient
consid
stratifi
analys
children
adult
mean
age
group
respiratori
viral
infect
lower
remain
patient
vs
year
p
differ
signific
stratifi
children
adult
limit
studi
first
chang
antiinfect
manag
retrospect
match
date
rtpcr
analysi
exact
time
specif
avail
leav
room
potenti
inaccuraci
known
whether
extent
factor
contribut
clinic
decis
start
stop
continu
antibiot
therapi
due
retrospect
natur
studi
possibl
consid
clinic
present
analysi
therefor
difficult
reproduc
decisionmak
process
primari
indic
antibiot
therapi
import
limit
clinic
judgement
remain
essenti
concern
use
antibiot
furthermor
data
consequ
rtpcr
result
antibiot
treatment
difficult
obtain
ambulatori
set
explain
rel
small
number
enrol
outpati
prospect
studi
ideal
rct
necessari
confirm
find
second
creat
categori
clinic
bacteri
clinic
viral
etiolog
mean
biomark
radiolog
present
antibiot
pretreat
done
arbitrarili
reflect
reallif
decisionmak
theoret
reflect
import
better
understand
find
howev
note
retrospect
actual
decisionmak
process
remain
unclear
third
studi
includ
patient
upper
lower
respiratori
tract
infect
exclud
patient
antibiot
pretreat
signific
underli
patholog
condit
may
bias
result
reflect
clinic
routin
algorithm
place
perform
rtpcr
test
appli
result
likewis
mirror
realworld
scenario
fourth
studi
multiplex
rtpcr
includ
respiratori
virus
newer
gener
assay
addit
cover
atyp
typic
bacteria
increas
detect
potenti
respiratori
pathogen
albeit
yet
unresolv
specif
issu
typic
bacteri
pathogen
might
also
repres
carriag
absenc
diseas
fifth
preval
rsv
underestim
studi
popul
hospit
children
rapid
detect
test
rsv
perform
initi
posit
addit
rtpcr
perform
studi
includ
patient
rtpcr
assay
respiratori
virus
perform
number
rsv
infect
lower
expect
epidemiolog
data
studi
reveal
reallif
impact
viral
multiplex
rtpcr
children
adult
limit
adult
improv
result
seen
context
biomark
radiolog
antibiot
pretreat
substanti
reduct
unnecessari
antibiot
prescript
seem
possibl
necessari
develop
structur
manag
algorithm
incorpor
molecular
diagnost
includ
bacteri
pathogen
need
prospect
test
efficaci
safeti
rti
